Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.
  • Developed a multi-species spatially explicit economic-epidemiological model to support an investment case for malaria elimination in the Asia-Pacific region in collaboration with UCSF
  • Developed a bespoke smartphone app for real time malaria surveillance data collection which has been adopted by the Cambodian national malaria control program.
  • Vivax costing and cost-effectiveness – drawing on extensive costing data collected during the IMPROV/OPRA studies, we produced the most extensive findings to date on the costs of vivax malaria to household and facilities, the global costs of vivax malaria and cost-benefit analyses of radical cure.
  • A simple deterministic model that can be used to compare the predicted impact of competing strategies for malaria elimination within minutes. This has a built-in front end designed such that it can be used by policy makers themselves
  • A spatially explicit individual based model, with detailed intervention logistics. This simulation platform can reproduce any intervention at any scale given enough data. There is a quite significant trade-off between the level of detail and the time it takes to offer a recommendation to the NMCPs. This platform has been used to replicate the large TME (targeted malaria elimination) trial in the Thai-Myanmar border. Its within host component is also being developed further to account for intricate PK/PD dynamics of new triple malaria therapies.